On Nov 05, 2025, INGN reported earnings of -0.13 USD per share (EPS) for Q3 25, beating the estimate of -0.22 USD, resulting in a 42.07% surprise. Revenue reached 92.39 million, compared to an expected 94.04 million, with a -1.76% difference. The market reacted with a -8.31% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.36 USD, with revenue projected to reach 86.75 million USD, implying an increase of 176.92% EPS, and decrease of -6.10% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
Intuitive Surgical Inc.
Report Date
Jan 22, 2026 For Q4 25
Estimate
$2.30
Actual
$2.52
Surprise
+9.86%
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.63%
FAQ
What were Inogen Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Inogen Inc reported EPS of -$0.13, beating estimates by 42.07%, and revenue of $92.39M, -1.76% below expectations.
How did the market react to Inogen Inc's Q3 2025 earnings?
The stock price moved down -8.31%, changed from $8.06 before the earnings release to $7.39 the day after.
When is Inogen Inc expected to report next?
The next earning report is scheduled for Feb 24, 2026.
What are the forecasts for Inogen Inc's next earnings report?
Based on 4
analysts, Inogen Inc is expected to report EPS of -$0.36 and revenue of $86.75M for Q4 2025.